Developing a universal vaccine to protect against influenza.
COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER: CLINICAL CORE
This study is testing a new flu vaccine that hopes to protect you from different types of the flu for a longer time, and if you join, you'll help researchers see how well it works and if it's safe for people.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-10369577 on NIH RePORTER |
What this research studies
This research focuses on creating a universal influenza vaccine that aims to provide broader and longer-lasting protection against various strains of the flu virus. The project involves designing and managing a Phase I clinical trial, which is the first step in testing the safety and effectiveness of this innovative vaccine in humans. Patients participating in this trial will help researchers understand how well the vaccine works and its potential to prevent influenza infections. The study is part of a collaborative effort by the National Institute of Allergy and Infectious Diseases (NIAID) to improve flu vaccination strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are healthy adults who are willing to participate in early-stage clinical trials for vaccine development.
Not a fit: Patients with severe allergies to vaccine components or those with compromised immune systems may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a more effective vaccine that protects against multiple strains of influenza, reducing the incidence of flu-related illnesses.
How similar studies have performed: Other research efforts have shown promise in developing universal vaccines for influenza, but this specific approach is innovative and still in early testing phases.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Walter, Emmanuel — Duke University
- Study coordinator: Walter, Emmanuel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.